Wikipedia

Magnesium deficiency

(Redirected from Hypomagnesia)

For treatment of magnesium deficiency, see Magnesium (medical use). For magnesium deficiency in plants, see chlorosis.

Magnesium deficiency is an electrolyte disturbance in which there is a low level of magnesium in the body.[3] Symptoms include tremor, poor coordination, muscle spasms, loss of appetite, personality changes, and nystagmus.[1][2] Complications may include seizures or cardiac arrest such as from torsade de pointes.[1] Those with low magnesium often have low potassium.[1]

Magnesium deficiency
Other namesHypomagnesia, hypomagnesemia
Magnesium
SpecialtyEndocrinology
SymptomsTremor, poor coordination, nystagmus, seizures[1]
ComplicationsSeizures, cardiac arrest (torsade de pointes), low potassium[1]
CausesAlcoholism, starvation, diarrhea, increased urinary loss, poor absorption from the intestines, certain medications[1][2]
Diagnostic methodBlood levels < 0.6 mmol/L (1.46 mg/dL)[1]
TreatmentMagnesium salts[2]
FrequencyRelatively common (hospitalized people)[2]

Causes include low dietary intake, alcoholism, diarrhea, increased urinary loss, and poor absorption from the intestines.[1][4][5] Some medications may also cause low magnesium, including proton pump inhibitors (PPIs) and furosemide.[2] The diagnosis is typically based on finding low blood magnesium levels, also called hypomagnesemia.[6] Normal magnesium levels are between 0.6 and 1.1 mmol/L (1.46–2.68 mg/dL) with levels less than 0.6 mmol/L (1.46 mg/dL) defining hypomagnesemia.[1] Specific electrocardiogram (ECG) changes may be seen.[1]

Treatment is with magnesium either by mouth or intravenously.[2] For those with severe symptoms, intravenous magnesium sulfate may be used.[1] Associated low potassium or low calcium should also be treated.[2] The condition is relatively common among people in hospitals.[2]

Signs and symptoms

edit

Deficiency of magnesium can cause tiredness, generalized weakness, muscle cramps, abnormal heart rhythms, increased irritability of the nervous system with tremors, paresthesias, palpitations, low potassium levels in the blood, hypoparathyroidism which might result in low calcium levels in the blood, chondrocalcinosis, spasticity and tetany, migraines, epileptic seizures,[7] basal ganglia calcifications[8] and in extreme and prolonged cases coma, intellectual disability or death.[9] Magnesium deficiency is strongly associated with and appears to contribute to obesity, insulin resistance, metabolic syndrome, and type 2 diabetes, although the causal mechanism is not fully understood.[10][4][5]

Causes

edit

Magnesium deficiency may result from gastrointestinal or kidney causes. Gastrointestinal causes include low dietary intake of magnesium, reduced gastrointestinal absorption or increased gastrointestinal loss due to rapid gastrointestinal transits. Kidney causes involve increased excretion of magnesium. Poor dietary intake of magnesium has become an increasingly important factor: many people consume diets high in refined foods such as white bread and polished rice which have been stripped of magnesium-rich plant fiber.[11]

Magnesium deficiency is common in hospitalized patients. Up to 12% of all people admitted to hospital, and as high as 60–65% of people in an intensive care unit (ICU), have hypomagnesemia.[12]

About 57% of the US population does not meet the US RDA for dietary intake of magnesium.[13] Kidneys are very efficient at maintaining body levels; however, if the diet is deficient, or certain medications such as diuretics or proton pump inhibitors are used,[14] or in chronic alcoholism,[15] levels may drop.

Deficiencies may be due to the following conditions:

Medications

edit

Genetics

edit

Metabolic abnormalities

edit

Other

edit
  • Chronic alcoholism: Alcohol intake leads to enhanced diuresis of electrolytes, possibly due to alcohol induced kidney tubular cell damage.[25] Hypomagnesemia is also thought to occur due to reduced magnesium intake due to malnutrition and increased gastrointestinal losses.[25][26][27][28][29] Hypomagnesemia is the most common electrolyte abnormality in those with chronic alcoholism.[25] Chronic hypomagnesemia in those with chronic alcoholism is associated with liver disease and a worse prognosis,[25]
  • Acute myocardial infarction: within the first 48 hours after a heart attack, 80% of patients have hypomagnesemia. This could be the result of an intracellular shift because of an increase in catecholamines,
  • Malabsorption,
  • Acute pancreatitis,
  • Fluoride poisoning,
  • Massive transfusion (MT) is a lifesaving treatment of hemorrhagic shock, but can be associated with significant complications.[30]

Pathophysiology

edit

Magnesium is ubiquitous in the human body as well as being present in all living organisms and the ion is a known co-factor in over known 300 enzymatic reactions including DNA and RNA replication, protein synthesis, acting as an essential co-factor of ATP during its phosphorylation via ATPase. It is also extensively involved in intracellular signaling.[20][25] It is involved in protein synthesis, regulating glucose, lipid and protein metabolism, muscle and nerve functioning, vascular tone (affecting blood vessel contraction, thus helping to regulate blood pressure), bone development, energy production, the maintenance of normal heart rhythm, and the regulation of glucose, among other important roles.[15][25] Physiologically, it acts as a calcium antagonist.[25] Thus, the effects of low magnesium are widespread. Low magnesium intake over time can increase the risk of illnesses, including high blood pressure and heart disease, diabetes mellitus type 2, osteoporosis, and migraines.[15]

Magnesium has several effects:

Potassium

edit

Low potassium levels are usually associated with hypomagnesemia. Low magnesium levels act to inhibit the sodium-potassium pump (Na-K-ATPase) which normally pumps sodium to the extracellular space and potassium into the intracellular space, using ATP as energy to pump both cations against their concentration gradient, to maintain relatively high levels of potassium in the intracellular compartment and high levels of sodium in the extracellular space.[25] Hypomagnesemia also causes activation of the Renal outer medullary potassium channel (ROMK), a potassium channel which causes potassium losses in the urine via the cortical collecting duct in the kidney.[25] And hypomagnesemia prevents low potassium levels from activating the sodium-chloride cotransporter (NCC) and downregulates NCC levels, which prevents sodium and chloride reabsorption from the kidney tubule.[25] The inhibition of the sodium-potassium pump results in more potassium remaining in the extracellular space (interstitial fluid and plasma). And this potassium is then lost as blood is filtered in the kidney as ROMK channel activation causes potassium losses in the cortical collecting duct and NCC inhibition causes decreased sodium-chloride reabsorption by kidney tubules, with subsequent increased sodium-chloride (and water) delivery to the distal tubule, and associated diuresis and kaliuresis (kidney potassium loss in the urine).[25] Overall, the net effect of low magnesium levels in the body is renal potassium losses (in the urine), thus clinically, low potassium levels are often refractory to supplementation without also correcting low magnesium levels.[25][31]

Patients with diabetic ketoacidosis should have their magnesium levels monitored to ensure that the serum loss of potassium, which is driven intracellularly by insulin administration, is not exacerbated by additional urinary losses. [citation needed]

Calcium

edit

Release of calcium from the sarcoplasmic reticulum is inhibited by magnesium. Thus hypomagnesemia results in an increased intracellular calcium level. This inhibits the release of parathyroid hormone, which can result in hypoparathyroidism and hypocalcemia. Furthermore, it makes skeletal and muscle receptors less sensitive to parathyroid hormone.[12]

Arrhythmia

edit

Magnesium is needed for the adequate function of the Na+/K+-ATPase pumps in cardiac myocytes, the muscles cells of the heart. A lack of magnesium inhibits reuptake of potassium, causing a decrease in intracellular potassium. This decrease in intracellular potassium results in tachycardia.[citation needed]

Pre-eclampsia

edit

Magnesium has an indirect antithrombotic effect upon platelets and endothelial function. Magnesium increases prostaglandins, decreases thromboxane, and decreases angiotensin II, microvascular leakage, and vasospasm through its function similar to calcium channel blockers.[citation needed] Convulsions are the result of cerebral vasospasm. The vasodilatatory effect of magnesium seems to be the major mechanism.

Asthma

edit

Magnesium exerts a bronchodilatatory effect, probably by antagonizing calcium-mediated bronchoconstriction.[32]

Neurological effects

edit

Diabetes mellitus

edit

Magnesium deficiency is frequently observed in people with type 2 diabetes mellitus, with an estimated prevalence ranging between 11 and 48%.[34] Magnesium deficiency is strongly associated with high glucose and insulin resistance, which indicate that it is common in poorly controlled diabetes.[35] Patients with type 2 diabetes and a magnesium deficiency have a higher risk of heart failure, atrial fibrillation and microvascular complications.[36] Oral magnesium supplements has been demonstrated to improve insulin sensitivity and lipid profile.[37][38][39] A 2016 meta-analysis not restricted to diabetic subjects found that increasing dietary magnesium intake, while associated with a reduced risk of stroke, heart failure, diabetes, and all-cause mortality, was not clearly associated with lower risk of coronary heart disease (CHD) or total cardiovascular disease (CVD).[40]

Homeostasis

edit

Magnesium rich foods include cereals, green vegetables (with magnesium being a main component of chlorophyll), beans, and nuts.[25] It is absorbed primarily in the small intestine via paracellular transport; passing between intestinal cells. Magnesium absorption in the large intestine is mediated by the transporters TRPM6 and TRPM7.[25]

The body contains about 25 grams of magnesium.[25] Of the body's magnesium, 50-60% is stored in bone, with the remainder, about 40-50%, being stored in muscle or soft tissue, with about 1% being in the plasma.[41] Therefore, normal plasma levels of magnesium may sometimes be seen despite a person being in a state of magnesium deficiency and plasma magnesium levels may underestimate the level of deficiency. Plasma magnesium levels may more accurately reflect magnesium stores when consideration is also given to urinary magnesium losses and oral intake of magnesium. [25]

Inside cells, 90-95% of magnesium is bound to ligands, including ATP, ADP, citrate, other proteins and nucleic acids.[25] In the plasma, 30% of magnesium is bound to proteins via free fatty acids, therefore elevated levels of free fatty acids are associated with hypomagnesemia as well as a possible risk of cardiovascular disease.[25]

The kidneys regulate magnesium levels by reabsorbing magnesium from the tubules. In the proximal tubule (at the beginning of the nephron, the functional unit of the kidney) 20% of magnesium is reabsorbed via paracellular transport with claudin 2 and claudin 12 forming channels to allow for reabsorption.[25] 70% of magnesium is reabsorbed in the thick ascending limb of the loop of Henle where claudins 16 and 19 form the channels to allow for reabsorption.[25] In the distal convoluted tubule, 5-10% of magnesium is reabsorbed transcellularly (through the cells) via the transporters TRPM6 and TRPM7. Epidermal growth factor and insulin activate TRPM6 and 7 and increase magnesium levels via increased renal reabsorption.[25]

Diagnosis

edit

Magnesium deficiency or depletion is a low total body level of magnesium; it is not easy to measure directly.[42]

Blood magnesium

edit

Typically the diagnosis is based on finding hypomagnesemia, a low blood magnesium level,[43] which often reflects low body magnesium;[6] however, magnesium deficiency can be present without hypomagnesemia, and vice versa.[42] A plasma magnesium concentration of less than 0.6 mmol/L (1.46 mg/dL) is considered to be hypomagnesemia;[1] severe disease generally has a level of less than 0.5 mmol/L (1.25 mg/dL).[2]

Electrocardiogram

edit

The electrocardiogram (ECG) change may show a tachycardia with a prolonged QT interval.[44] Other changes may include prolonged PR interval, ST segment depression, flipped T waves, and long QRS duration.[1]

Treatments

edit
Main article: Magnesium (medical use)

Treatment of magnesium deficiency depends on the degree of deficiency and the clinical effects. Replacement by mouth is appropriate for people with mild symptoms, while intravenous replacement is recommended for people with severe effects.[45]

Numerous oral magnesium preparations are available. In two trials of magnesium oxide, one of the most common forms in magnesium dietary supplements because of its high magnesium content per weight, was found to be less bioavailable than magnesium citrate, chloride, lactate or aspartate.[46][47] Amino-acid chelate was also less bioavailable.[48]

Intravenous magnesium sulfate (MgSO4) can be given in response to heart arrhythmias to correct for hypokalemia, preventing pre-eclampsia, and has been suggested as having a potential use in asthma.[1]

Food

edit

Food sources of magnesium include leafy green vegetables, beans, nuts, and seeds.[49]

Epidemiology

edit

Hypomagnesemia may be seen in 3-10% of the general population.[25] It is present in an estimated 10-30% of people with diabetes, 10-60% of hospitalized people and greater than 65% of people in the ICU.[25][2] In hospitalized patients, hypomagnesemia is associated with an increased length of stay. And in those in an ICU, it is associated with a higher risk of requiring mechanical ventilation, and death.[50][51] In population based cohort studies, chronic magnesium deficiency was associated with an increased risk of cardiovascular death and overall death.[25][52]

History

edit

Magnesium deficiency in humans was first described in the medical literature in 1934.[53]

Plants

edit
 
A plant with magnesium deficiency

Magnesium deficiency is a detrimental plant disorder that occurs most often in strongly acidic, light, sandy soils, where magnesium can be easily leached away. Magnesium is an essential macronutrient constituting 0.2-0.4% of plants' dry matter and is necessary for normal plant growth.[54] Excess potassium, generally due to fertilizers, further aggravates the stress from magnesium deficiency,[55] as does aluminium toxicity.[56]

Magnesium has an important role in photosynthesis because it forms the central atom of chlorophyll.[54] Therefore, without sufficient amounts of magnesium, plants begin to degrade the chlorophyll in the old leaves. This causes the main symptom of magnesium deficiency, interveinal chlorosis, or yellowing between leaf veins, which stay green, giving the leaves a marbled appearance. Due to magnesium's mobile nature, the plant will first break down chlorophyll in older leaves and transport the Mg to younger leaves which have greater photosynthetic needs. Therefore, the first sign of magnesium deficiency is the chlorosis of old leaves which progresses to the young leaves as the deficiency progresses.[57] Magnesium also acts as an activator for many critical enzymes, including ribulosebisphosphate carboxylase (RuBisCO) and phosphoenolpyruvate carboxylase (PEPC), both essential enzymes in carbon fixation. Thus low amounts of Mg lead to a decrease in photosynthetic and enzymatic activity within the plants. Magnesium is also crucial in stabilizing ribosome structures, hence, a lack of magnesium causes depolymerization of ribosomes leading to premature aging of the plant.[54] After prolonged magnesium deficiency, necrosis and dropping of older leaves occurs. Plants deficient in magnesium also produce smaller, woodier fruits.

Magnesium deficiency in plants may be confused with zinc or chlorine deficiencies, viruses, or natural aging, since all have similar symptoms. Adding Epsom salts (as a solution of 25 grams per liter or 4 oz per gal) or crushed dolomitic limestone to the soil can rectify magnesium deficiencies. An organic treatment is to apply compost mulch, which can prevent leaching during excessive rainfall and provide plants with sufficient amounts of nutrients, including magnesium.[58]

See also

edit

References

edit
  1. ^ a b c d e f g h i j k l m n Soar J, Perkins GD, Abbas G, Alfonzo A, Barelli A, Bierens JJ, et al. (October 2010). "European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution". Resuscitation. 81 (10): 1400–1433. doi:10.1016/j.resuscitation.2010.08.015. PMID 20956045.
  2. ^ a b c d e f g h i j "Hypomagnesemia". Merck Manuals Professional Edition. Retrieved 27 October 2018.
  3. ^ "Definition of Magnesium Deficiency". MedicineNet.com. Archived from the original on 31 May 2014. Retrieved 31 May 2014.
  4. ^ a b de Baaij JH, Hoenderop JG, Bindels RJ (January 2015). "Magnesium in man: implications for health and disease". Physiological Reviews. 95 (1): 1–46. CiteSeerX 10.1.1.668.9777. doi:10.1152/physrev.00012.2014. PMID 25540137. S2CID 4999601.
  5. ^ a b Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH (January 2016). "Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?". Diabetes. 65 (1): 3–13. doi:10.2337/db15-1028. PMID 26696633.
  6. ^ a b Goldman L, Schafer AI (2015). Goldman-Cecil Medicine E-Book. Elsevier Health Sciences. p. 775. ISBN 9780323322850.
  7. ^ Yuen AW, Sander JW (June 2012). "Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis". Epilepsy Research. 100 (1–2): 152–156. doi:10.1016/j.eplepsyres.2012.02.004. PMID 22406257. S2CID 23147775.
  8. ^ "Basal Ganglia Calcification with Hypomagnesemia". www.japi.org. Archived from the original on 2022-06-30. Retrieved 2021-06-03.
  9. ^ a b c d e Viering DH, de Baaij JH, Walsh SB, Kleta R, Bockenhauer D (July 2017). "Genetic causes of hypomagnesemia, a clinical overview". Pediatric Nephrology. 32 (7): 1123–1135. doi:10.1007/s00467-016-3416-3. PMC 5440500. PMID 27234911.
  10. ^ Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV, Pinotti L, Maier JA, Cazzola R (February 2021). "Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes". Nutrients. 13 (2): 320. doi:10.3390/nu13020320. ISSN 2072-6643. PMC 7912442. PMID 33499378.
  11. ^ DiNicolantonio JJ, O'Keefe JH, Wilson W (2018). "Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis". Open Heart. 5 (1): e000668. doi:10.1136/openhrt-2017-000668. PMC 5786912. PMID 29387426.
  12. ^ a b Agus ZS (July 1999). "Hypomagnesemia". Journal of the American Society of Nephrology. 10 (7): 1616–1622. doi:10.1681/ASN.V1071616. PMID 10405219.
  13. ^ "Nutrient Intakes Percent of population 2 years old and over with adequate intakes based on average requirement". Community Nutrition Mapping Project. 2009-07-29. Retrieved 2012-02-11.
  14. ^ "FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs)". fda.gov. F.D.A. U.S. Food and Drug Administration. Retrieved 8 November 2014.
  15. ^ a b c "Magnesium: Fact Sheet for Health Professionals". nih.gov. National Institutes of Health. Retrieved 8 November 2014.
  16. ^ a b Whang R, Hampton EM, Whang DD (February 1994). "Magnesium homeostasis and clinical disorders of magnesium deficiency". The Annals of Pharmacotherapy. 28 (2): 220–226. doi:10.1177/106002809402800213. PMID 8173141. S2CID 23442909.
  17. ^ Gragossian A, Bashir K, Friede R (2021). "Hypomagnesemia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29763179. Retrieved 2021-06-03.
  18. ^ "Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication - Low Magnesium Levels Can Be Associated With Long-Term Use". www.fda.gov. Archived from the original on 2011-03-04.
  19. ^ Sheen E, Triadafilopoulos G (April 2011). "Adverse effects of long-term proton pump inhibitor therapy". Digestive Diseases and Sciences. 56 (4): 931–950. doi:10.1007/s10620-010-1560-3. PMID 21365243. S2CID 34550326.
  20. ^ a b al-Ghamdi SM, Cameron EC, Sutton RA (November 1994). "Magnesium deficiency: pathophysiologic and clinical overview". American Journal of Kidney Diseases. 24 (5): 737–752. doi:10.1016/s0272-6386(12)80667-6. PMID 7977315.
  21. ^ Viering D, Schlingmann KP, Hureaux M, Nijenhuis T, Mallett A, Chan MM, et al. (February 2022). "Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA". Journal of the American Society of Nephrology. 33 (2): 305–325. doi:10.1681/ASN.2021050596. PMC 8819995. PMID 34607911.
  22. ^ Chareonpong-Kawamoto N, Yasumoto K (February 1995). "Selenium deficiency as a cause of overload of iron and unbalanced distribution of other minerals". Bioscience, Biotechnology, and Biochemistry. 59 (2): 302–306. doi:10.1271/bbb.59.302. PMID 7766029.
  23. ^ Johnson S (2001). "The multifaceted and widespread pathology of magnesium deficiency". Medical Hypotheses. 56 (2). Elsevier BV: 163–170. doi:10.1054/mehy.2000.1133. ISSN 0306-9877. PMID 11425281.
  24. ^ Al-Ghamdi SM, Cameron EC, Sutton RA (1994). "Magnesium Deficiency: Pathophysiologic and Clinical Overview". American Journal of Kidney Diseases. 24 (5). Elsevier BV: 737–752. doi:10.1016/s0272-6386(12)80667-6. ISSN 0272-6386. PMID 7977315.
  25. ^ a b c d e f g h i j k l m n o p q r s t u v w x Touyz RM, de Baaij JH, Hoenderop JG (6 June 2024). "Magnesium Disorders". New England Journal of Medicine. 390 (21): 1998–2009. doi:10.1056/NEJMra1510603. PMID 38838313.
  26. ^ Rivlin RS (October 1994). "Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review)". Journal of the American College of Nutrition. 13 (5): 416–423. doi:10.1080/07315724.1994.10718430. PMID 7836619.
  27. ^ Gomella LG, Haist SA, eds. (2007). "Chapter 9. Fluids and Electrolytes". Clinician's Pocket Reference: The Scut Monkey (11th ed.). McGraw Hill. ISBN 978-0-07-145428-5.
  28. ^ Desai S, Seidler M (2017). "Metabolic & Endocrine Emergencies". In Stone C, Humphries RL (eds.). Current Diagnosis & Treatment: Emergency Medicine (8th ed.). McGraw Hill. ISBN 978-0-07-184061-3.
  29. ^ Flink EB (December 1986). "Magnesium deficiency in alcoholism". Alcoholism: Clinical and Experimental Research. 10 (6): 590–594. doi:10.1111/j.1530-0277.1986.tb05150.x. PMID 3544909.
  30. ^ Sihler KC, Napolitano LM (January 2010). "Complications of massive transfusion". Chest. 137 (1): 209–220. doi:10.1378/chest.09-0252. PMID 20051407.
  31. ^ Huang CL, Kuo E (October 2007). "Mechanism of hypokalemia in magnesium deficiency". Journal of the American Society of Nephrology. 18 (10): 2649–2652. doi:10.1681/ASN.2007070792. PMID 17804670.
  32. ^ Mills R, Leadbeater M, Ravalia A (August 1997). "Intravenous magnesium sulphate in the management of refractory bronchospasm in a ventilated asthmatic". Anaesthesia. 52 (8): 782–785. doi:10.1111/j.1365-2044.1997.176-az0312.x. PMID 9291766.
  33. ^ Maier JA, Locatelli L, Fedele G, Cazzaniga A, Mazur A (January 2023). "Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration". International Journal of Molecular Sciences. 24 (1): 223. doi:10.3390/ijms24010223. hdl:2434/951571. ISSN 1422-0067.
  34. ^ Pham PC, Pham PM, Pham SV, Miller JM, Pham PT (March 2007). "Hypomagnesemia in patients with type 2 diabetes". Clinical Journal of the American Society of Nephrology. 2 (2): 366–373. doi:10.2215/CJN.02960906. PMID 17699436.
  35. ^ Pham PC, Pham PM, Pham SV, Miller JM, Pham PT (March 2007). "Hypomagnesemia in patients with type 2 diabetes". Clinical Journal of the American Society of Nephrology. 2 (2): 366–373. doi:10.1530/EJE-16-0517. PMID 17699436.
  36. ^ Oost LJ, van der Heijden AA, Vermeulen EA, Bos C, Elders PJ, Slieker RC, et al. (August 2021). "Serum Magnesium Is Inversely Associated With Heart Failure, Atrial Fibrillation, and Microvascular Complications in Type 2 Diabetes". Diabetes Care. 44 (8): 1757–1765. doi:10.2337/dc21-0236. PMID 34385344. S2CID 236991270.
  37. ^ Rodríguez-Morán M, Guerrero-Romero F (April 2003). "Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial". Diabetes Care. 26 (4): 1147–1152. doi:10.2337/diacare.26.4.1147. PMID 12663588.
  38. ^ Asbaghi O, Moradi S, Nezamoleslami S, Moosavian SP, Hojjati Kermani MA, Lazaridi AV, Miraghajani M (March 2021). "The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials". Biological Trace Element Research. 199 (3): 861–873. Bibcode:2021BTER..199..861A. doi:10.1007/s12011-020-02209-5. PMID 32468224. S2CID 218978772.
  39. ^ Verma H, Garg R (2 February 2017). "Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis". Journal of Human Nutrition and Dietetics. 30 (5). Wiley: 621–633. doi:10.1111/jhn.12454. ISSN 0952-3871. PMID 28150351. S2CID 19778171.
  40. ^ Fang X, Wang K, Han D, He X, Wei J, Zhao L, Imam MU, Ping Z, Li Y, Xu Y, Min J, Wang F (2016). "Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies". BMC Medicine. 14 (1): 210. doi:10.1186/s12916-016-0742-z. ISSN 1741-7015. PMC 5143460. PMID 27927203.
  41. ^ Jahnen-Dechent W, Ketteler M (1 February 2012). "Magnesium basics". Clinical Kidney Journal. 5 (Suppl 1): i3–i14. doi:10.1093/ndtplus/sfr163. PMC 4455825. PMID 26069819.
  42. ^ a b Swaminathan R (May 2003). "Magnesium metabolism and its disorders". The Clinical Biochemist. Reviews. 24 (2): 47–66. PMC 1855626. PMID 18568054.
  43. ^ Davis CP (29 March 2021). "Hypomagnesemia". Medterms medical dictionary a-z list. MedicineNet. Archived from the original on 31 May 2014. Retrieved 31 May 2014.
  44. ^ Famularo G, Gasbarrone L, Minisola G (September 2013). "Hypomagnesemia and proton-pump inhibitors". Expert Opinion on Drug Safety. 12 (5): 709–716. doi:10.1517/14740338.2013.809062. PMID 23808631. S2CID 2726503.
  45. ^ Durlach J, Durlach V, Bac P, Bara M, Guiet-Bara A (December 1994). "Magnesium and therapeutics". Magnesium Research. 7 (3–4): 313–328. PMID 7786695.
  46. ^ Firoz M, Graber M (December 2001). "Bioavailability of US commercial magnesium preparations". Magnesium Research. 14 (4): 257–262. PMID 11794633.
  47. ^ Lindberg JS, Zobitz MM, Poindexter JR, Pak CY (February 1990). "Magnesium bioavailability from magnesium citrate and magnesium oxide". Journal of the American College of Nutrition. 9 (1): 48–55. doi:10.1080/07315724.1990.10720349. PMID 2407766.
  48. ^ Walker AF, Marakis G, Christie S, Byng M (September 2003). "Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study". Magnesium Research. 16 (3): 183–191. PMID 14596323.
  49. ^ "Abridged List Ordered by Nutrient Content in Household Measure Source: USDA National Nutrient Database for Standard Reference Legacy (2018) Nutrients: Magnesium, Mg(mg)" (PDF). United States Department of Agriculture. Retrieved May 20, 2020.
  50. ^ Upala S, Jaruvongvanich V, Wijarnpreecha K, Sanguankeo A (July 2016). "Hypomagnesemia and mortality in patients admitted to intensive care unit: a systematic review and meta-analysis". QJM. 109 (7): 453–459. doi:10.1093/qjmed/hcw048. PMID 27016536.
  51. ^ Peres IT, Hamacher S, Oliveira FL, Thomé AM, Bozza FA (December 2020). "What factors predict length of stay in the intensive care unit? Systematic review and meta-analysis". Journal of Critical Care. 60: 183–194. doi:10.1016/j.jcrc.2020.08.003. PMID 32841815.
  52. ^ Ye L, Zhang C, Duan Q, Shao Y, Zhou J (19 September 2023). "Association of Magnesium Depletion Score With Cardiovascular Disease and Its Association With Longitudinal Mortality in Patients With Cardiovascular Disease". Journal of the American Heart Association. 12 (18): e030077. doi:10.1161/JAHA.123.030077. PMC 10547298. PMID 37681518.
  53. ^ Hirschfelder AD, Haury VG (1934). "Clinical Manifestations of High and Low Plasma Magnesium; Dangers of Epsom Salt Purgation in Nephritis". Journal of the American Medical Association. 102 (14): 1138. doi:10.1001/jama.1934.02750140024010.
  54. ^ a b c Huner NP, Hopkins W (2008-11-07). "3 & 4". Introduction to Plant Physiology 4th Edition. John Wiley & Sons, Inc. ISBN 978-0-470-24766-2.
  55. ^ Ding Y, Chang C, Luo W (2008). "High Potassium Aggravates the Oxidative Stress Induced by Magnesium Deficiency in Rice Leaves". Pedosphere. 18 (3): 316–327. doi:10.1016/S1002-0160(08)60021-1.
  56. ^ Merhaut DJ (2006). "Magnesium". In Barker AV, Pilbeam DJ (eds.). Handbook of plant nutrition. Boca Raton: CRC Press. p. 154. ISBN 9780824759049.
  57. ^ Hermans C, Vuylsteke F, Coppens F (2010). "Systems Analysis of the responses to long-term magnesium deficiency and restoration in Arabidopsis thaliana". New Phytologist. 187 (1): 132–144. Bibcode:2010NewPh.187..132H. doi:10.1111/j.1469-8137.2010.03257.x. hdl:2066/83962. PMID 20412444.
  58. ^ "Problem Solving: Magnesium Deficiency". Gardeners' World Magazine. 6 March 2019.
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=Magnesium_deficiency&oldid=1259433381"